About this trial
Multiple Sclerosis (MS) is the most common NDD affecting young people worldwide. MS can seriously affect quality of life and hinder daily functional activities. Therefore, living with MS is a daunting task for both patients and their families. With the prediction of an increase in life expectancy, it is also expected that MS will pose major challenges to healthcare providers in the UAE and globally in terms of its clinical management and financial implications. This proposed project aims to develop structured AR scenarios that integrate dual-tasking exercises commonly used in MS physiotherapy, specifically designed to meet the needs of PwMS. The primary goal is to evaluate the feasibility, acceptability, and potential benefits of these AR scenarios as a rehabilitation tool for PwMS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Neurologist-confirmed diagnosis of MS according to the revised McDonald criteria and PDDS score of ≤6
Age above 18 years;
Affected by relapsing remitting and secondary progressive MS
Successful completion of Physical Activity Readiness Questionnaire (PAR-Q)
Disqualifiers
Acute illness or injury that would prevent safe participation in an exercise program
Presence of any other neurological conditions (e.g., stroke),
Presence of severe psychiatric illness other than anxiety or depression
According to the Diagnostic and Statistical Manual of Mental Disorders, 5th -Edition (DSM- V),
Trial design
Parallel
Treatments tested in this trial
Augmented Reality Exercises
Other interventionAll participants in the experimental group will then be given a tutorial on how to perform the proposed exercises based on AR and they will be asked to familiarise themselves with the system. While the participants in the control group will be given a leaflet of physical exercises and they will be instructed by a physical therapist on the correct performance of these exercises
Treatment groups
Trial outcomes
Primary outcomes
Gait Velocity- single-task (BTS GAITLAB)
Measured using BTS GAITLAB (Physiotherapy Laboratory, University of Sharjah) during walking under single-task condition (walking only). Report mean gait velocity across trials. Higher = faster walking.
Gait velocity during dual-task walking (m/s)
Measured using BTS GAITLAB during walking under dual-task cognitive condition. Report mean gait velocity across trials. Higher = faster walking under dual-task.
Secondary outcomes
Balance - Berg Balance Scale (BBS)
Balance assessed using the Berg Balance Scale. Report total score (0-56). Higher = better balance.
Activities-specific Balance Confidence (ABC) Scale score (0-100%)
Balance confidence assessed using the ABC scale. Report total/mean percentage score (0-100%). Higher = greater confidence.
Five Times Sit-to-Stand test time (seconds)
Functional lower-limb performance assessed using five times chair sit-to-stand test. Report completion time in seconds. Lower = better.
Functional Mobility Scale (FMS) rating
Functional mobility assessed using the Functional Mobility Scale. Report FMS rating (per standard scoring). Higher = better mobility.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: